Melanie Ivarsson joins Protas Board of Directors
Melanie Ivarsson OBE brings over 25 years of leadership in life sciences and clinical development to Protas.
The latest in smarter trials
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
Protas continues global expansion of Cantata
Cantata platform is now being used in 12 countries, supporting 2 trials simultaneously.
Protas welcomes Annalisa Jenkins to Board of Directors
Dr Annalisa Jenkins brings over 25 years of life sciences experience to Protas.
Protas launches novel unified clinical trial management platform
Protas announces the launch of its new Cantata platform.
Protas welcomes new Chief Finance Officer
Maggie Payne has joined the Executive Team responsible for the leadership of Protas.
Policy: Protas contributes to major clinical trial milestones
Protas has played a significant role in shaping three major policy efforts.
WHO guidance incorporates Good Clinical Trials Collaborative’s work
Principles from global community initiative, which includes Protas, forms basis of new WHO guidance.
Protas collaborates with GSK to advise on optimising protocol development
Protas will advise GSK on clinical trial protocols across a range of late-phase investigational products.
Protas gains ISO 9001 certification for high standards of quality
The international accreditation acknowledges our approach to quality.
Apollo Therapeutics and Protas partner to advance therapeutic programmes
Protas will provide expertise to the portfolio biopharma on a range of drug development programmes.
O’Shaughnessy review: Protas, Oxford and Good Clinical Trials Collaborative respond
Together, the three organisations are calling for actions not words in The Lancet.
Esther Krofah joins Protas Board of Directors
Protas is delighted to welcome Esther Krofah MPP to its Board of Directors.